Research Library

Currently the Nigerian state is undergoing a civil war, with the protagonist being the Salafi-jihadi group popularly called Boko Haram. During the years since 2011, Boko Haram has morphed from being a local Salafi-jihadi group into a major player in West African radicalism. During the period since July 2014, Boko Haram has clearly set the establishment of a physical Islamic state in Nigeria as its goal and has fought the Nigerian military to a draw. While there is some support among the U.S. foreign policy community for proactively combating Boko Haram, the Nigerian civil war is not one that commands much interest among Americans as a whole. Nor is it clear the manner in which aid for fighting Boko Haram could be rendered or what exactly would be the acceptable scope of such a conflict for the United States. In this paper, author David Cook argues that there are only extreme circumstances under which the United States should involve itself in the Nigerian civil war and that thus far this conflict does not coincide with those circumstances. However, it is possible that with Boko Haram set upon the establishment of an Islamic state there could come a set of circumstances under which this reality could change.

As the United States once again ramps up involvement in Iraq, it makes sense to examine U.S. interests and strategy while considering what might constitute realistic parameters for participation and outcome. In this issue brief, energy fellow Jim Krane explores answers to the question "What are U.S. interests in Iraq and how are they best pursued?"

The changing regional geopolitics of the Middle East have created new opportunities for the Gulf states to engage in Arab-Israeli conflict resolution after the Arab Spring. This policy report examines the potential role that the six Gulf Cooperation Council (GCC) states — Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates (UAE) — might play in Israeli-Palestinian conflict resolution. It presents policy recommendations on how the Gulf states can engage with regional and international partners and build upon the greater space for action as the shifting parameters of Middle East politics create new regional pathways for action and cooperation.

Thursday's Baker Institute Blog carries a commentary from fellow Joe Barnes on President Obama’s Sept. 10, 2014, speech on ISIS and Iraq.

Fellow Joe Barnes looks at the kerfuffle arising from former secretary of state Hillary Clinton’s critical — much-publicized — response to President Obama’s description of his foreign policy as “don’t do stupid stuff.”

While much media attention recently has focused on the geopolitical fault lines that connect Syria’s violence to wider region-wide trends, the plight of individual women, men, and children displaced within Syria or living in camps beyond its borders shows no sign of ending. As Secretary of State John Kerry has stated, the humanitarian situation in Syria is "an outrage" but the violence only looks set to worsen as opposition groups turn on each other and radical trans-national elements feed off the resulting vacuum of authority and control. This is the task as the international community prepares to reconvene in Switzerland on January 22, writes Baker Institute fellow Kristian Coates Ulrichsen in the Baker Institute Blog.

Despite the political nature of stem cell research, this area of science continues to flourish in the United States. In 2011, the NIH funded approximately US$1.2 billion in stem cell research — a steady increase from past years — with US$123 million devoted to human embryonic stem cells. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2011, accounting for approximately 38 percent of the world total. Approximately one-quarter of these publications were collaborations with authors from other countries.

Experts from the Baker Institute Center for Energy Studies examines issues in global energy.

The NIH, which has an annual budget of over US$31 billion, is the world’s largest biomedical research agency and is a major strength for science in the U.S. Despite the political nature of stem cell research, this area of science has flourished across the country. In 2010, the NIH funded approximately US$1.3 billion in stem cell research. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2010 — approximately 40% of the world total. The average citation rate was 4.12 per article, with six articles amassing 100 citations in less than 18 months after release.